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Abstract 
Purpose: To evaluate the antifungal and cytotoxic activities of four medicinal plants from Tanzania, 
namely, Mystroxylon aethiopicum, Lonchocarpus capassa, Albizia anthelmentica and Myrica salicifolia. 
Methods: The plant materials were subjected to extraction using dichloromethane, ethyl acetate and 
distilled water. The minimum inhibition concentration (MIC) of the extracts against Candida albicans and 
Cryptococcus neoformans was determined by microdilution method. The lowest concentration which 
showed no fungal growth was considered as MIC. The cytotoxic effect of the extracts was determined 
using brine shrimp toxicity assay. 
Results: Lonchocarpus capassa leaf extracts exhibited antifungal activity against test fungal strains 
with MIC range of 0.78 – 3.13 mg/mL with Lonchocarpus capassa aqueous leaf extract (LCAL) inhibiting 
C. albicans and C. neoformans at MIC value of 0.78 mg/mL. Cytotoxicity assay revealed that LCAL 
extract which displayed good antifungal activity, was cytotoxic against brine shrimp larvae with half-
maximal lethal concentration (LC50) value of 17.86 µg/mL. Interestingly, 33 % of plant extracts exhibited 
high cytotoxicity with LC50 values below that of the standard anticancer drug, cyclophosphamide (16.57 
µg/mL).  
Conclusion: The results obtained suggest that LCAL needs to be further investigated for its 
phytochemical composition to unravel its antifungal secondary metabolites. Furthermore, some of the 
plant extracts are potential anticancer agents.  
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The importance of medicinal plants in solving the 
healthcare problems of the world is gaining 
attention [1]. The World Health Organization 
(WHO) estimated that 80 % of the world's 
population has been using medicinal plants for 
many years as a primary healthcare [2]. Some of 
these medicinal plants involve the use of crude 
plant extracts in the form of infusion, decoction or 
tincture which may contain some molecules, 
often with indefinite biological effects [3].  
Medicinal plants therefore, have been proved to 
be a good source of antimicrobial agents 
exemplified by a number of lead compounds that 
are currently at different stages of clinic 
evaluation [4]. 
 
Fungal diseases reported to be the main causes 
of morbidity and mortality worldwide [5]. Human 
infections particularly those involving skin, 
constitute a serious problem especially in tropical 
and subtropical developing countries [6]. In 
humans, fungal infections range from superficial 
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to deeply invasive or disseminated [7]. According 
to Hamza et al [8], fungal infections particularly 
those caused by Candida albicans and 
Cryptococcus neofromans are the most 
challenging infections facing immune 
compromised patients such as HIV/AIDS 
patients.  
 
Drugs currently available to treat fungal 
infections have serious limitations such as 
development of fungal resistance and toxic side 
effects [9]. Despite these limitations, screening 
for alternative means of treating fungal infections 
is desirable. Use of medicinal plants can be a 
good approach for counteracting some limitations 
facing conventional drugs [10]. However, most of 
the available information regarding the medicinal 
potential of these plants is not provided with 
scientific data. This study therefore reports the 
antifungal and cytotoxicity activity of M. 
aethiopicum, L. capassa, A. anthelmentica and 




Acquisition of materials 
 
Dichloromethane was purchased from Avantor 
Perfomance Materials Limited, Gujarat, India. 
Dimethyl sulphoxide (DMSO) and ethyl acetate 
were bought from RFCL Limited, Haryana, India. 
Sabouraud dextrose agar and Saboraud 
dextrose broth were supplied by HIMEDIA 
Laboratories Pvt. Limited, Mumbai, India. 
Candida albicans (ATCC 90028) and 
Cryptococcus neoformans (clinical isolate) were 
obtained from the department of Microbiology, 
Muhimbili University of Health and Allied 
Sciences (MUHAS). Standard fluconazole and 
iodonitrotetrazolium chloride were supplied by 
Lincoln Pharmaceuticals LTD, Khatraj, India and 
SIGMA® (Sigma- Aldrich®, St. Louis, USA) 
respectively. Brine Shrimps eggs were obtained 
from the Aquaculture innovations (Grahamstown 
6140, South Africa) and sea salt was prepared 
locally by evaporating water collected from the 
Indian Ocean, along the Dar es Salaam coast, 
Tanzania. 
 
Preparation of plant extracts and extraction 
 
The plant materials were collected from different 
parts of Arusha region. Leaves, stems and roots 
of L. capassa and A. anthelmentica were 
collected from Esilalei village while the same 
plant parts of M. aethiopicum and M. salicifolia 
were collected from Imbibya and Engalaoni 
villages respectively. Plant species were 
identified by Mr. Gabriel Laizer, a senior botanist 
from Tropical Pesticide Research Institute (TPRI) 
and voucher specimens coded MA-01, LC-02, 
AA-03 and MS-04 for M. aethiopicum, L. 
capassa, A. anthelmentica and M. salicifolia, 
respectively, are kept at Nelson Mandela African 
Institution of Science and Technology (NM-
AIST), Arusha, Tanzania. The plant materials 
were air-dried and pulverized into fine particles 
using electric blender. For non-polar and medium 
polar extraction, pulverized materials (250 g of 
leaves, stem and root barks) were sequentially 
successively macerated in dichloromethane and 
ethyl acetate for 48 h. The respective extracts 
were filtered through Whatman No. 1 filter paper 
on a plug of glass wool in a glass column and 
solvents were evaporated through the vacuum 
using a rotary evaporator. For polar extraction, 
the same pulverized materials (250 g of leaves, 
stem and root barks) were added to a 1 L of 
distilled water at 70 °C and allowed to cool until 
reaching 40 °C in a water bath. The extracts 
were sieved and centrifuged at 5000 rpm for 10 
min. The supernatant was collected and filtered 
using Whatman No. 1 filter paper and dried by 
freezing to eliminate water by sublimation. All 
extracts were stored in a deep freezer at -20 °C 
for further activities. 
 
Determination of antifungal activity 
 
Minimum inhibitory concentrations (MICs) were 
determined by microdilution method using 96-
well plates according to procedure reported by 
[11]. The plates were first preloaded with 50 μL 
of Saboraud’s dextrose broth media in each well 
followed by addition of 50 μL of 100 mg/mL 
extract (prepared in DMSO) into the first wells of 
each row so as to make a total volume of 100 μL 
in each of the first row wells. The contents were 
thoroughly mixed and 50 μL of the same were 
drawn from each of the first row wells and put 
into the next row wells. The process was 
repeated down the columns to the last wells at 
the bottom from which 50 μL were discarded. 
Thereafter, 50 μL of the selected fungal 
suspension (0.5 Mac Farhland standard turbidity) 
were added to each well thus making a final 
volume of 100 μL per well. Fluconazole was 
used in two rows of each plate to serve as 
standard positive control drugs against the test 
fungal strains while DMSO was used as negative 
control. Likewise, Saboraud’s dextrose broth was 
used to monitor fungal growth respectively. The 
plates were then incubated at 37 °C for 24 h. 
MICs for each extract were determined by adding 
20 μL of 0.02 % p-iodonitrotetrazolium (INT) 
chloride dye in each well followed by incubation 
at 32 °C for 1 h. Fungal growth was indicated by 
change of colour to pink. The lowest 
concentration which showed no fungal growth 
was considered as MIC.  
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Brine shrimp lethality test 
 
Brine shrimp (Artemia salina) larvae were used 
as indicator animals for preliminary cytotoxicity 
assay of the extracts as reported by [12]. Artificial 
sea water was prepared by dissolving sea salt 
(3.8 g) in 1 L distilled water. The salt solution was 
poured into a glass container and the shrimp 
eggs were spread and a lamp was illuminated 
from one side in order to attract hatched shrimps. 
The hatched shrimps (mature nauplii) were 
collected after 36 and 48 h of hatching. Stock 
solution of each extract was prepared by 
dissolving 40 mg/mL in DMSO. Different levels of 
concentrations (240, 120, 80, 40, 24 and 8 
µg/mL) were prepared by drawing different 
volumes from the stock solutions and then added 
in a 10 mL universal bottle containing 10 brine 
shrimps larvae. The volume was then adjusted to 
5 mL with artificial sea water prepared by 
dissolving 3.8 g of sea salt in 1 L of distilled 
water. Each level of concentration was tested in 
duplicate. Cyclophosphamide was used as 
standard positive control drug whereas DMSO 
and artificial sea water as negative control. The 
number of surviving larvae was determined after 
24 h and the percentage mortality was 
determined by comparing the mean surviving 




Microsoft Excel 2010 computer software was 
used to obtain regression equation, from which 
LC16, LC50, LC84 and 95 % CI values were 
calculated. The results were used to document 
safety and cytotoxic activity of plants extracts. 
LC50 values greater than 100 µg/mL were 
considered as non-toxic and less than 100 µg/mL 
as toxic [12]. One-way analysis of variance 
(ANOVA) was carried out using Statistica 
software version 8 to determine the effect of 
plant extract concentration on brine shrimp 
mortality. Confirmation of statistical difference 
was by Fisher’s LSD test with the level of 






The findings presented as minimum inhibition 
concentrations (MIC) indicated that plant extracts 
possessed varying antifungal potencies as 
summarized in Table 1 and 2. Lonchocarpus 
capassa extracts showed activity against C. 
albicans and C. neoformans with MIC range of 
0.78 – 25 mg/mL. Myrica salicifolia and Albizia 
anthelmentica extracts exhibited antifungal 
activity with MIC range of 3.13 – 12.5 mg/mL 
whilst Mystroxylon aethiopicum extracts had MIC 
range of 6.25 – 12.5 mg/mL.  
 
In this study, the antifungal investigation of L. 
capassa revealed that, the dichloromethane leaf 
extract (LCDL) and ethyl acetate (LCEL) 
exhibited antifungal activity against tested fungal 
strains with narrow MIC range of 1.56 – 3.13 
mg/mL and 0.78 – 3.13 mg/mL respectively 
(Table 1). Conversely, the L. capassa aqueous 
leaf (LCAL) extract displayed antifungal activity 
with MIC value of 0.78 mg/mL against both C. 
albicans and C. neoformans. Besides leaf 
extracts which exhibited antifungal activity 
against selected fungal strains, the stem and root 
bark extracts exhibited low antifungal activity with 
MIC range of 6.25 – 25 mg/mL. The antifungal 
activity of L. capassa extracts against C. albicans 
and C. neoformans which have been implicated 
to cause death to immune compromised patients 
such as HIV/AIDS patients is a novel finding. 
Albizia anthelmentica dichloromethane leaf 
(AADL) and ethyl acetate (AAEL) extracts 
exhibited moderate antifungal activities with MIC 
value of 3.13 mg/mL against C. albicans whereas 
the aqueous leaf (AAAL) extract had the same 
MIC value of 3.13 mg/mL against C. neoformans 
(Table 2). The stem bark extract exhibited low 
antifungal activity which is evidenced by MIC 
values of 6.25 and 12.5 mg/mL against C. 
neoformans and C. albicans respectively. 
Apparently, the root bark extracts of this plant 
were less active against selected fungal strains 
with wide MIC range of 6.25 – 12.5 mg/mL.  
 
Antifungal investigation of M. salicifolia revealed 
that leaf extracts exhibited antifungal activity with 
MIC value of 3.13 mg/mL against C. neoformans 
as indicated in Table 2. The M. salicifolia ethyl 
acetate stem bark (MSES) and aqueous (MSAS) 
extracts had low antifungal activity against 
selected fungal strains with MIC range of 6.25 – 
12.5 mg/mL whereas the dichloromethane stem 
bark (MSDS) extract was less active against both 
C. albicans and C. neoformans with MIC value of 
12.5 mg/mL. Likewise, M. salicifolia aqueous root 
bark (MSAR) extract exhibited low antifungal 
activity against C. albicans and C. neoformans 
with wide MIC range of 6.25 – 12.5 mg/mL. The 
M. salicifolia dichloromethane root bark (MSDR) 
and ethyl acetate (MSER) extracts displayed 
antifungal activity against tested fungal strains 
with MIC value of 12.5 mg/mL. 
 
Results from this study revealed that M. 
aethiopicum extracts displayed the least 
antifungal activity as compared with the rest of 
plants extracts tested. M. aethiopicum 
dichloromethane leaf (MADL) and ethyl acetate 
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(MAEL) extracts exhibited wide MIC range of 
6.25 – 12.5 mg/mL against selected fungal 
strains. M. aethiopicum aqueous leaf (MAAL) 
extract displayed MIC value of 6.25 mg/mL 
against both tested fungal species (Table 1). 
Likewise, M. aethiopicum dichloromethane stem 
bark (MADS) and ethyl acetate (MAES) extracts 
had low antifungal activity against selected 
fungal strains which is evidenced by MIC range 
of 6.25 – 12.5 mg/mL whereas aqueous stem 
bark (MAAS) extract showed MIC value of 6.25 
mg/mL against both C. albicans and C. 
neoformans. Furthermore, M. aethiopicum ethyl 
acetate root bark (MAER) and aqueous (MAAR) 
extracts exhibited wide MIC range of 6.25 – 12.5 
mg/mL against tested fungal strains while the 
dichloromethane root bark (MADR) extract had 





Findings from this study revealed that M. 
aethiopicum root bark extracts was the most 
toxic against brine shrimp larvae with narrow 
LC50 range of 1.43 – 2.96 µg/mL as shown in 
Table 3. L. capassa aqueous stem bark (LCAS) 
extract exhibited cytotoxicity activity against brine 
shrimp with LC50 value of 5.71 µg/mL followed by 
ethyl acetate root bark (LCER) and aqueous leaf 
(LCAL) extract with LC50 values of 13.78 µg/mL 
and 17.86 µg/mL respectively as shown in Table 
3. The A. anthelmentica extracts exhibited LC50 
values below 100 µg/mL (Table 4) against brine 
shrimp and therefore considered as toxic. 
However, the A. anthelmentica aqueous root 
bark (AAAR) extract exhibited higher cytotoxicity 
activity with LC50 value of 3.08 µg/mL followed by 
ethyl acetate root bark (AAER) extract which had 
LC50 value of 4.86 µg/mL. The A. anthelmentica 
ethyl acetate leaf (AAEL) and aqueous stem bark 
(AAAS) extracts displayed LC50 values of 7.76 
µg/mL and 9.99 µg/mL respectively. With regard 
to M. salicifolia, the ethyl acetate root bark 
(MSER) extract were active against brine shrimp 
larvae with LC50 value of 2.59 µg/mL followed by 
dichloromethane leaf (MSDL) extract which 
exhibited LC50 value of 5.98 µg/mL as shown in 
Table 4. In addition, this study revealed that 
there was a significant difference (p < 0.05) in 
the concentration of some extracts tested as 
shown in Table 5 and 6. Furthermore, the degree 
of lethality increased with increase in the 
concentration for all plants tested and the 
standard control. 
 




Minimum inhibitory concentration (MIC, mg/mL) 
C. albicans C. neoformans 
MADL 6.25 12.50 
MAEL 6.25 12.50 
MAAL 6.25 6.25 
MADS 12.50 6.25 
MAES 12.50 6.25 
MAAS 6.25 6.25 
MADR 12.50 12.50 
MAER 6.25 12.50 
MAAR 6.25 12.50 
LCDL 1.56 3.13 
LCEL 3.13 0.78 
LCAL 0.78 0.78 
LCDS 25.00 25.00 
LCES 25.00 25.00 
LCAS 12.50 6.25 
LCDR 25.00 25.00 
LCER 25.00 12.50 
LCAR 12.50 6.25 
Fluconazole 1.56 0.78 
Key: MADL=M. aethiopicum dichloromethane leaf extract, MAEL=M. aethiopicum ethyl acetate leaf extract, 
MAAL=M. aethiopicum aqueous leaf extract, MADS=M. aethiopicum dichloromethane stem bark extract, 
MAES=M. aethiopicum ethyl acetate stem bark extract, MAAS=M. aethiopicum aqueous stem bark extract, 
MADR= M. aethiopicum dichloromethane root bark extract, MAER=M. aethiopicum ethyl acetate root bark 
extract, MAAR=M. aethiopicum aqueous root bark extract, LCDL=L. capassa dichloromethane leaf extract, 
LCEL=L. capassa ethyl acetate leaf extract, LCAL=L. capassa aqueous leaf extract, LCDS=L. capassa 
dichloromethane stem bark extract, LCES=L. capassa ethyl acetate stem bark extract, LCAS=L. capassa 
aqueous stem bark extract, LCDR=L. capassa dichloromethane root bark extract, LCER=L. capassa ethyl 
acetate root bark extract, LCAR=L. capassa aqueous root bark extract 
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Minimum inhibitory concentration  
(MIC, mg/mL) 
C. albicans C. neoformans 
AADL 3.13 6.25 
AAEL 3.13 6.25 
AAAL 6.25 3.13 
AADS 12.50 6.25 
AAES 12.50 6.25 
AAAS 12.50 6.25 
AADR 12.50 12.50 
AAER 12.50 6.25 
AAAR 6.25 6.25 
MSDL 12.50 3.13 
MSEL 12.50 3.13 
MSAL 6.25 3.13 
MSDS 12.50 12.50 
MSES 12.50 6.25 
MSAS 12.50 6.25 
MSDR 12.50 12.50 
MSER 12.50 12.50 
MSAR 12.50 6.25 
Fluconazole 1.56 0.78 
Key: AADL=A. anthelmentica dichloromethane leaf extract, AAEL=A. anthelmentica ethyl acetate leaf extract, 
AAAL=A. anthelmentica aqueous leaf extract, AADS=A. anthelmentica dichloromethane stem bark extract, 
AAES=A. anthelmentica ethyl acetate stem bark extract, AAAS=A. anthelmentica aqueous stem bark extract, 
AADR=A. anthelmentica dichloromethane root bark extract, AAER=A. anthelmentica ethyl acetate root bark 
extract, AAAR=A. anthelmentica aqueous root bark extract, MSDL=M. salicifolia dichloromethane leaf extract, 
MSEL=M. salicifolia ethyl acetate leaf extract, MSAL=M. salicifolia aqueous leaf extract, MSDS=M. salicifolia 
dichloromethane stem bark extract, MSES=M. salicifolia ethyl acetate stem bark extract, MSAS=M. salicifolia 
aqueous stem bark extract, MSDR=M. salicifolia dichloromethane root bark extract, MSER=M. salicifolia ethyl 
acetate root bark extract, MSAR=M. salicifolia aqueous root bark extract. 
 
Table 3: Brine shrimp lethality test of M. aethiopicum and L. capassa (leaf, stem and root bark) 
 






MADL Y= 60.75 log x - 50.35 44.85 39.90 - 50.41 0.92 
MAEL Y= 46.64 log x - 42.07 94.24 61.64 - 144.09 0.96 
MAAL Y= 41.43 log x - 47.49 225.43 133.57 - 380.45 0.95 
MADS Y= 16.78 log x + 32.04 11.75 2.77 - 49.80 0.88 
MAES Y= 37.41 log x - 0.34 22.15 13.06 - 37.60 0.99 
MAAS Y= 43.84 log x - 38.65  105.25 64.22 - 172.51 0.88 
MADR Y= 25.19 log x + 44.54 1.68 0.71 - 3.96 0.90 
MAER Y= 27.92 log x + 36.85 2.96 1.36 - 6.43 0.92 
MAAR Y= 21.86 log x + 46.58 1.43 0.47 - 4.36 0.95 
LCDL Y= 28.17 log x - 9.25 126.92 58.78 - 274.08 0.97 
LCEL Y= 19.22 log x + 16.22 57.16 18.50 - 176.61 0.94 
LCAL Y= 22.94 log x + 21.28 17.82 7.54 - 42.31 0.98 
LCDS Y= 26.07 log x + 0.89 76.55 35.82 - 163.58 0.97 
LCES Y= 10.19 log x + 28.74 121.84 11.29 - 1315.41 0.89 
LCAS Y= 14.87 log x + 38.76 5.71 1.11 - 29.22 0.96 
LCDR Y= 27.03 log x + 8.37 34.70 15.55 - 77.41 0.96 
LCER Y= 35.62 log x + 9.43 13.78 7.90 - 24.01 0.95 
LCAR Y= 43.29 log  x - 37.96 107.67 68.15 - 170.11 0.94 
Cyclophosphamide Y= 19.81 log x + 25.85 16.57 3.57 - 76.83 0.89 
Key: MADL=M. aethiopicum dichloromethane leaf extract, MAEL=M. aethiopicum ethyl acetate leaf extract, 
MAAL=M. aethiopicum aqueous leaf extract, MADS=M. aethiopicum dichloromethane stem bark extract, 
MAES=M. aethiopicum ethyl acetate stem bark extract, MAAS=M. aethiopicum aqueous stem bark extract, 
MADR= M. aethiopicum dichloromethane root bark extract, MAER=M. aethiopicum ethyl acetate root bark 
extract, MAAR=M. aethiopicum aqueous root bark extract, LCDL=L. capassa dichloromethane leaf extract, 
LCEL=L. capassa ethyl acetate leaf extract, LCAL=L. capassa aqueous leaf extract, LCDS=L. capassa 
dichloromethane stem bark extract, LCES=L. capassa ethyl acetate stem bark extract, LCAS=L. capassa 
aqueous stem bark extract, LCDR=L. capassa dichloromethane root bark extract, LCER=L. capassa ethyl 
acetate root bark extract, LCAR=L. capassa aqueous root bark extract 
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Table 4: Brine shrimp lethality test of A. anthelmentica and M. salicifolia (leaf, stem and root bark) 
 






AADL Y= 23.15 log x + 8.53 61.90 24.26 - 157.97 0.85 
AAEL Y= 33.96 log x + 19.78 7.76 4.33 - 13.89 0.97 
AAAL Y= 40.82 log x - 11.02 31.25 18.37 - 53.16 100 
AADS Y= 33.34 log x + 0.70 30.10 15.71 - 57.67 100 
AAES Y= 19.13 log x + 18.73 43.12 12.14 - 153.15 0.94 
AAAS Y= 34.51 log x + 15.50 9.99 5.63 - 17.74 0.99 
AADR Y= 32.64 log x + 3.052 27.45 14.97 - 50.35 0.91 
AAER Y= 25.87 log x + 32.24 4.86 2.10 - 11.23 0.98 
AAAR Y= 26.37 log x + 37.11 3.08 1.23 - 7.73 0.96 
MSDL Y= 16.46 log x + 37.208 5.98 1.10 - 32.72 0.87 
MSEL Y= 25.78 log x + 8.94 39.16 16.89 - 90.83 0.97 
MSAL Y= 18.49 log x + 20.58 38.96 10.49 - 144.53 0.99 
MSDS Y= 34.60 log x - 5.62 40.50 20.10 - 81.61 0.90 
MSES Y= 14.66 log x + 18.71 136.11 31.01 - 597.39 0.95 
MSAS Y= 23.05 log x - 17.43 841.62 293.96 - 2409.56 100 
MSDR Y= 26.83 log x - 7.92 144.19 68.93 - 301.65 0.96 
MSER Y= 15.28 log x + 43.70 2.59 0.53 - 12.59 0.94 
MSAR Y= 21.62 log x - 4.46 330.75 107.73 - 1015.44 0.90 
Cyclophosphamide Y= 19.81 log x + 25.85 16.57 3.57 - 76.83 0.89 
Key: AADL=A. anthelmentica dichloromethane leaf extract, AAEL=A. anthelmentica ethyl acetate leaf extract, 
AAAL=A. anthelmentica aqueous leaf extract, AADS=A. anthelmentica dichloromethane stem bark extract, 
AAES=A. anthelmentica ethyl acetate stem bark extract, AAAS=A. anthelmentica aqueous stem bark extract, 
AADR=A. anthelmentica dichloromethane root bark extract, AAER=A. anthelmentica ethyl acetate root bark 
extract, AAAR=A. anthelmentica aqueous root bark extract, MSDL=M. salicifolia dichloromethane leaf extract, 
MSEL=M. salicifolia ethyl acetate leaf extract, MSAL=M. salicifolia aqueous leaf extract, MSDS=M. salicifolia 
dichloromethane stem bark extract, MSES=M. salicifolia ethyl acetate stem bark extract, MSAS=M. salicifolia 
aqueous stem bark extract, MSDR=M. salicifolia dichloromethane root bark extract, MSER=M. salicifolia ethyl 




Validation of ethnomedical information of plants commonly used by ethnic groups has been a strategy 
in the discovery of novel bioactive secondary metabolites [13]. However, biological screening of plants 
for a targeted biological properties has also been regarded an optional strategy towards unveiling 
medicinal potential of plants. Despite these efforts, there are still some plants that have never been 
screened for biological potentials. That is why M. aethiopicum, L. capassa, A. anthelmentica and M. 
salicifolia growing in Tanzania were evaluated for antifungal and cytotoxicity activities. Leaves of L. 
capassa were reported by [14] as a remedy for skin infections. Since fungus is the main cause of skin 
infections in humans, it is therefore evident that L. capassa leaves extract is a potential antifungal 
herbal product. The MIC value of 0.78 mg/mL recorded by L. capassa aqueous leaf extract (LCAL) 
against C. albicans and C. neoformans provide evidence that polar compounds in the leaves extract 
of this plant is a potent antifungal agent. Furthermore, the high cytotoxicity (LC50 17.86 µg/mL) 
supports its use as topical antifungal agent. According to [15], plant extracts that are recommended in 
the drug discovery initiatives are those with MIC value of less than 1 mg/mL, and thus plant extracts 
that exhibited MIC value of 0.78 mg/mL in this study are potential source of drug templates. However, 
[15] further elaborated that extracts with low antimicrobial activity should also be reported as they can 
be incorporated with other extracts to improve it biological importance. 
 
A. anthelmentica dichloromethane leaf (AADL) and ethyl acetate (AAEL) extracts had selectivity 
against C. albicans with MIC value of 3.13 mg/mL. Conversely, the aqueous leaf (AAAL) extract had 
selectivity against C. neoformans with same MIC value of 3.13 mg/mL. Earlier phytochemical 
investigations on the leaves of A. anthelmentica reported the presence of phenolics and terpenes [16]. 
Since terpenes have been reported to possess antifungal properties [17], it is therefore postulated that 
the antifungal properties exhibited by A. anthelmentica might be due to the presence of terpenes. 
Findings from this study are in line with the previous study conducted by [18] which reported that 
leaves of A. anthelmentica growing in Kenya exhibited high antifungal activity as compared with other 
parts of the plant. Another study conducted by [19] on antifungal activities of A. anthelmentica by disc 
diffusion method in the eastern part of Tanzania reported that the extract was inactive against C. 
albicans with an average inhibition zone of 15 mm. 
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             Table 5: Brine shrimp lethality test of M. aethiopicum and L. capassa (leaf, stem and root bark) 
 
Pant extract Mean mortality (µg/mL) 
240 120 80 40 24 10 P-value 
MADL 9.00 ± 1.00c 7.50 ± 0.50bc 7.00 ± 0.00abc 5.50 ± 1.50ab 4.50 ± 0.50ad 2.50 ± 0.50d 0.01 
MAEL 6.00 ± 1.00a 5.50 ± 0.50a 4.00 ± 1.00a 3.00 ± 2.00a 2.00 ± 1.00a 1.00 ± 1.00a 0.12 
MAAL 10.00 ± 0.00d 5.50 ± 0.50c 3.00 ± 0.00a 3.00 ± 1.00a 1.50 ± 0.50ab 0.50 ±0.50 b 0.00 
MADS 7.00 ± 2.00a 6.50 ± 0.50a 6.50 ± 1.50a 6.00 ± 0.00a 6.00 ± 1.00a 4.50 ± 1.50a 0.79 
MAES 9.00 ± 1.00a 7.5 0± 0.50a 7.00 ± 0.00a 6.00 ± 0.00a 5.50 ± 0.50a 3.50 ± 2.50a 0.13 
MAAS 7.50 ± 0.50f 6.00 ± 0.00e 5.00 ± 0.00d 3.00 ± 0.00c 2.00 ± 0.00b 1.00 ± 0.00a 0.00 
MADR 10.00 ± 0.00b 9.50 ± 0.50ab 9.50 ± 0.50ab 9.00 ± 0.00ab 8.00 ± 0.00ac 7.00 ± 1.00c 0.04 
MAER 7.50 ± 0.50f 6.00 ± 0.00e 5.00 ± 0.00d 3.00 ± 0.00c 2.00 ± 0.00b 1.00 ± 0.00a 0.00 
MAAR 10.00 ± 0.00a 10.00 ± 0.00a 9.50 ± 0.50a 9.50 ± 0.50a 9.50 ± 0.50a 8.50 ± 0.50a 0.25 
LCDL 6.00 ± 1.00d 5.00 ±1.00de 4.00 ± 0.00a 3.00 ± 0.00bc 3.00 ± 0.00ab 2.00 ± 0.00ab 0.02 
LCEL 6.00 ± 1.00a 5.50 ± 1.50a 5.50 ± 0.50a 5.50 ± 0.00a 4.00 ± 0.00a 4.00 ± 0.00a 0.31 
LCAL 7.50 ± 0.50a 7.00 ± 1.00a 6.50 ± 0.50a 6.00 ± 0.00a 5.00 ± 1.00a 4.50 ± 0.50a 0.11 
LCDS 6.50 ± 0.50d 5.00 ± 0.00bcd 5.50 ± 0.50cd 4.00 ± 0.00abc 3.50 ± 0.50ab 3.00 ± 1.00a 0.03 
LCES 5.50 ± 0.50a 5.00 ± 3.00a 4.50 ± 0.50a 4.00 ± 0.00a 4.00 ± 2.00a 4.00 ± 1.00a 0.97 
LCAS 7.50 ± 1.50a 7.00 ± 1.00a 6.00 ± 1.00a 6.00 ± 1.00a 5.50 ± 1.50a 5.50 ± 1.50a 0.82 
LCDR 7.50 ± 0.50a 6.00 ± 1.00a 5.50 ± 0.50a 5.50 ± 0.50a 4.50 ± 0.50a 3.50 ± 1.50a 0.14 
LCER 10.00 ± 0.00a 8.00 ± 2.00a 7.50 ± 0.50a 6.50 ± 0.50a 5.50 ± 0.50a 5.00 ± 0.00a 0.05 
LCAR 6.50 ± 1.50c 6.00 ± 0.00c 4.00 ± 0.00bc 2.50 ± 0.50ab 2.00 ± 1.00ab 1.00 ± 0.00a 0.01 
Cyclophosphamide 7.00a ± 1.00a 6.00a ± 1.00a 6.50a ± 0.50a 5.50a ± 0.50a 4.50a ± 0.50a 4.00a ± 1.00a 0.19 
Key: Values are expressed as mean ± SEM; values followed by different letters denote statistical significance according to Fisher’s LSD test (p<0.05), MADL=M. aethiopicum 
dichloromethane leaf extract, MAEL=M. aethiopicum ethyl acetate leaf extract, MAAL=M. aethiopicum aqueous leaf extract, MADS=M. aethiopicum dichloromethane stem bark 
extract, MAES=M. aethiopicum ethyl acetate stem bark extract, MAAS=M. aethiopicum aqueous stem bark extract, MADR= M. aethiopicum dichloromethane root bark extract, 
MAER=M. aethiopicum ethyl acetate root bark extract, MAAR=M. aethiopicum aqueous root bark extract, LCDL=L. capassa dichloromethane leaf extract, LCEL=L. capassa 
ethyl acetate leaf extract, LCAL=L. capassa aqueous leaf extract, LCDS=L. capassa dichloromethane stem bark extract, LCES=L. capassa ethyl acetate stem bark extract, 
LCAS=L. capassa aqueous stem bark extract, LCDR=L. capassa dichloromethane root bark extract, LCER=L. capassa ethyl acetate root bark extract, LCAR=L. capassa 
aqueous root bark extract. 
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                Table 6: Brine shrimp lethality test of A. anthelmentica and M. salicifolia (leaf, stem and root bark)  
 
Pant extract Mean mortality (µg/mL) 
240 120 80 40 24 10 P-value 
AADL 7.00 ± 0.00a 5.50 ± 0.50a 4.50 ± 2.50a 4.00 ± 0.00a 4.00 ± 2.00a 3.50 ± 0.50a 0.52 
AAEL 10.00 ± 0.00d 9.50 ± 0.50d 8.00 ± 0.00c 6.50 ± 0.50ab 7.50 ± 0.50bc 5.50 ± 0.50a 0.00 
AAAL 7.50 ± 0.50a 7.50 ± 0.50a 6.50 ± 0.50a 6.00 ± 0.00ac 4.50 ± 0.50bc 3.00 ± 1.00b 0.00 
AADS 8.00 ± 2.00a 7.00 ± 1.00a 6.50 ± 1.50a 4.50 ± 0.50a 4.50 ± 0.50a 3.50 ± 0.50a 0.17 
AAES 8.00 ± 0.00d 6.00 ± 0.00b 4.50 ± 0.50ab 4.00 ± 1.00a 3.50 ± 0.50a 1.00 ± 0.00c 0.00 
AAAS 10.00 ± 0.00b 8.50 ± 0.50ab 8.00 ± 1.00ab 7.00 ± 1.00a 6.50 ± 0.50a 2.00 ± 0.00c 0.00 
AADR 7.50 ± 0.50a 7.00 ± 2.00a 7.00 ± 2.00a 6.00 ± 1.00a 5.00 ± 2.00a 3.00 ± 1.00a 0.28 
AAER 9.50 ± 0.50a 8.00 ± 1.00a 8.00 ± 0.00a 7.50 ± 0.50a 6.50 ± 0.50a 6.00 ± 1.00a 0.09 
AAAR 10.00 ± 0.00a 9.00 ± 0.00a 9.00 ± 1.00a 7.50 ± 0.50a 6.50 ± 0.50a 6.50 ± 1.50a 0.08 
MSDL 9.00 ± 0.00a 6.50 ± 2.50a 6.50 ± 0.50a 6.50 ± 0.50a 6.50 ± 0.50a 4.00 ± 1.00a 0.23 
MSEL 8.50 ± 1.50a 8.50 ± 0.50a 5.00 ± 0.50a 5.50 ± 1.50a 4.50 ± 0.50a 3.50 ± 0.50a 0.05 
MSAL 6.50 ± 0.50a 5.50 ± 0.50a 5.00 ± 0.00a 5.00 ± 1.00a 4.50 ± 1.50a 4.00 ± 0.00a 0.41 
MSDS 9.00 ± 0.00e 6.00 ± 1.00c 5.50 ± 0.50bc 4.00 ± 0.00ab 3.00 ± 0.00a 1.00 ± 0.00d 0.00 
MSES 5.50 ± 0.50a 5.00 ± 0.00a 4.50 ± 0.50a 4.00 ± 1.00a 3.50 ± 0.50a 3.50 ± 0.50a 0.21 
MSAS 3.00 ± 1.00a 3.00 ± 1.00a 2.00 ± 1.00a 2.00 ± 1.00a 1.50 ± 0.50a 1.00 ± 0.00a 0.41 
MSDR 6.00 ± 1.00a 5.50 ± 0.50a 4.00 ± 0.00a 3.50 ± 0.50a 3.00 ± 1.00a 2.00 ± 1.00a 0.06 
MSER 8.00 ± 1.00a 7.50 ± 1.50a 7.50 ± 1.50a 6.50 ± 1.50a 6.00 ± 1.00a 6.00 ± 0.00a 0.76 
MSAR 5.00 ± 1.00a 3.50 ± 2.50a 3.00 ± 0.00a 3.00 ± 1.00a 3.00 ± 0.00a 1.50 ± 0.50a 0.54 
Cyclophosphamide 7.00 ± 1.00a 6.00 ± 1.00a 6.50 ± 0.50a 5.50 ± 0.50a 4.50 ± 0.50a 4.00 ± 1.00a 0.19 
Key: Values are expressed as mean ± SEM, numbers followed by different letters denote statistical significance according to Fisher’s LSD test (p<0.05), AADL=A. 
anthelmentica dichloromethane leaf extract, AAEL=A. anthelmentica ethyl acetate leaf extract, AAAL=A. anthelmentica aqueous leaf extract, AADS=A. anthelmentica 
dichloromethane stem bark extract, AAES=A. anthelmentica ethyl acetate stem bark extract, AAAS=A. anthelmentica aqueous stem bark extract, AADR=A. anthelmentica 
dichloromethane root bark extract, AAER=A. anthelmentica ethyl acetate root bark extract, AAAR=A. anthelmentica aqueous root bark extract, MSDL=M. salicifolia 
dichloromethane leaf extract, MSEL=M. salicifolia ethyl acetate leaf extract, MSAL=M. salicifolia aqueous leaf extract, MSDS=M. salicifolia dichloromethane stem bark extract, 
MSES=M. salicifolia ethyl acetate stem bark extract, MSAS=M. salicifolia aqueous stem bark extract, MSDR=M. salicifolia dichloromethane root bark extract, MSER=M. 
salicifolia ethyl acetate root bark extract, MSAR=M. salicifolia aqueous root bark extract 
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Antifungal investigation of M. salicifolia revealed 
that, leaf extracts selectively inhibited the growth 
of C. neoformans with MIC value of 3.13 mg/mL. 
This suggests that leaves of this plant are 
potential source of drug leads for the treatment of 
fungal infections caused by C. neoformans. 
According to Godfrey et al [20], utilization of 
leaves is highly recommended for sustainability 
of plants as the use of roots and stems increases 
risk of plants extinction. These results are in 
agreement with the traditional use of M. salicifolia 
leaves by Pare people in the Northern Tanzania 
for treatment of skin diseases [21]. Regarding M. 
aethiopicum, none of the extract exhibited 
antifungal activity with MIC value below 3.13 
mg/mL and therefore suggest that the plant does 
not contain active ingredients against selected 
fungal strains.  
 
In the cytotoxicity assay, brine shrimp lethality 
test (BST) was used to predict the potential 
cytotoxicity effect of extracts from M. 
aethiopicum, L. capassa, A. anthelmintica and M. 
salicifolia. According to [22], the BST is the rapid, 
inexpensive and simple bioassay for testing plant 
extracts bioactivity which in most cases 
correlates with cytotoxic and antitumor 
properties. Additionally, [12] demonstrated that 
plant extracts with LC50 value greater than 100 
µg/mL are considered as non-toxic while LC50 
value less than 100 µg/mL as toxic. Findings 
from this study revealed that M. aethiopicum root 
bark extracts were the most toxic against brine 
shrimp larvae which is evidenced by LC50 range 
of 1.43 – 2.96 µg/mL. The highest susceptibility 
shown by brine shrimp larvae towards root bark 
extracts of M. aethiopicum suggests that the root 
bark is the potential antitumor agents. The L. 
capassa stem bark and leaf extracts 
demonstrated cytotoxicity activity against brine 
shrimp with LC50 value range of 5.71 – 17.86 
µg/mL. These results collaborate with the 
previous cytotoxicity investigation study of the 
same plant growing in Tabora region, Tanzania 
which gave LC50 value of 17.8 µg/mL on brine 
shrimp [23]. Bark and leaves of this plant are 
therefore a potential anticancer herbal product. 
Interestingly, cytotoxicity results of L. capassa 
aqueous leaf (LCAL) extracts are consistent with 
the results of a standard anticancer drug 
cyclophosphamide which demonstrated LC50 
value of 16.57 µg/mL.  
 
In this study, the cytotoxicity results displayed by 
A. anthelmentica are in agreement with previous 
study conducted by [24] where LC50 value below 
100 µg/mL was reported for the root bark extract 
of the same plant species. The Myrica salicifolia 
ethyl acetate root bark (MSER) and 
dichloromethane leaf (MSDL) extracts 
demonstrated a potential source of antitumor 
agent as evidenced by LC50 values of 2.59 and 
5.98 µg/mL respectively. The sensitivity shown 
by brine shrimp against ethyl acetate root bark 
and dichloromethane leaf extracts provide a 
circumstantial evidence that secondary 
metabolites in the root barks and leaves of M. 
salicifolia might be a good source of anticancer 
compounds. According to Moshi et al [23] a plant 
extract with LC50 value below 20 µg/mL have a 
likelihood of yielding anticancer compounds. 
Previous cytotoxicity investigation of M. salicifolia 
extracts in Kenya proven that aqueous extracts 
had high cytotoxicity against brine shrimp larvae 
[25]. These findings however, collaborate with 
the present findings, despite the geographical 




The extracts of L. capassa, A. anthelmintica and 
M. salicifolia exhibit vaying degrees of antifungal 
activities against C. albicans and C. neoformans 
whereas extract of M. aethiopicum displayed the 
least antifungal activity compared with the rest of 
the plant extracts tested. A majority of the 
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